Amapula, Roxan S.

HRN: 28-88-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
CO-AMOXICLAV 625MG (TAB)
04/19/2026
04/25/2026
PO
625mg
BID
Sp RMLE And Repair, PROM
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines